Yusuke Takeda Selected Research

Hepatitis B Surface Antigens (HBsAg)

11/2014	Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.
1/2012	Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yusuke Takeda Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 03/2010
10	POEMS Syndrome (Syndrome, POEMS) 01/2024 - 08/2008
6	Leukemia 04/2024 - 02/2012
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 05/2017
6	Multiple Myeloma 01/2021 - 01/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 01/2014
5	Lymphoma (Lymphomas) 10/2018 - 01/2012
4	Infections 06/2023 - 01/2012
4	Albuminuria 01/2022 - 08/2017
3	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 08/2008
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 04/2013
3	Hemorrhage 01/2021 - 01/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2012
2	Chronic Limb-Threatening Ischemia 12/2023 - 02/2023
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 08/2008
2	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2019
2	Fibrosis (Cirrhosis) 01/2022 - 10/2019
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021 - 01/2015
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
2	Emphysema 05/2019 - 04/2013
2	Residual Neoplasm 01/2019 - 07/2015
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 05/2017 - 06/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2014 - 02/2012
1	Bronchiolitis Obliterans Syndrome 06/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2023
1	Ischemia 02/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Pulmonary Hypertension 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Plasma Cell Neoplasms 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Werner Syndrome (Werner's Syndrome) 01/2022
1	Neutropenia 01/2022
1	Exanthema (Rash) 01/2022
1	Nausea 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Breast Ductal Carcinoma 01/2021
1	Ductal Carcinoma 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Immunoglobulin Light-chain Amyloidosis 01/2021
1	Proteinuria 01/2021

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 12/2016 - 10/2013
4	Bortezomib (Velcade)FDA Link 01/2015 - 01/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 08/2008
3	CytokinesIBA 01/2022 - 06/2011
3	Proteasome InhibitorsIBA 01/2022 - 02/2014
3	rho-Associated KinasesIBA 01/2022 - 08/2017
3	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 01/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 08/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2015 - 01/2012
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2015
2	Immunomodulating AgentsIBA 01/2022 - 07/2019
2	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2015
2	fasudil (AT 877)IBA 01/2021 - 08/2017
2	AnticoagulantsIBA 07/2019 - 01/2019
2	Immunoglobulin M (IgM)IBA 01/2019 - 01/2018
2	SteroidsIBA 11/2018 - 04/2018
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2014 - 01/2012
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2024
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 04/2024
1	Nerve Growth Factor (NGF)IBA 01/2024
1	Adapalene (Differin)FDA LinkGeneric 02/2023
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2023
1	Amino Acids FDA Link 10/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	APTIBA 01/2022
1	ixazomibIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	DNA HelicasesIBA 01/2022
1	Busulfan (Busulfex)FDA Link 12/2021
1	Myosin-Light-Chain PhosphataseIBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	Keratin-7 (Cytokeratin 7)IBA 01/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	PTC596IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021

Therapy/Procedure

10	Therapeutics 06/2023 - 01/2012
8	Stem Cell Transplantation 01/2021 - 01/2012
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
6	Transplantation 01/2021 - 01/2015
5	Hematopoietic Stem Cell Transplantation 06/2023 - 11/2014
2	Surgical Amputation (Amputations) 12/2023 - 02/2023
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 10/2011
2	Oral Administration 10/2019 - 01/2019
2	Aftercare (After-Treatment) 01/2019 - 01/2015
2	Radiotherapy 01/2019 - 10/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2023
1	Brain-Computer Interfaces 01/2023
1	Autologous Transplantation 01/2022
1	Drug Tapering 01/2022
1	Pneumonectomy (Lung Volume Reduction) 01/2022